CHM 10.5% 2.1¢ chimeric therapeutics limited

Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial, page-16

  1. 7,798 Posts.
    lightbulb Created with Sketch. 3326
    Notice how her job title is gradually growing in status?

    Bec's official appointment was COO, then in an early interview it became cheerfully referred to as "soon-to-be CEO" and now its COO / acting CEO.

    Haha... forget the "acting" and just appoint her the CEO for god's sake!!!

    Its like she has been employed as the CEO (doing the job of a CEO) but on trial - with trainer-wheels strapped to her. From what we have seen of her so far, she is doing a far better job than half the CEOs that head most of the speccie resource companies and done it for decades.
    Last edited by Shellbell: Today, 16:43
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
0.002(10.5%)
Mkt cap ! $18.39M
Open High Low Value Volume
1.9¢ 2.2¢ 1.9¢ $53.04K 2.550M

Buyers (Bids)

No. Vol. Price($)
3 240967 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 922473 1
View Market Depth
Last trade - 15.54pm 22/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.